Coping with Huntington's Disease in Patients and At-Risk Individuals

被引:0
|
作者
Snow, Abigail L. B. [1 ,2 ]
Ciriegio, Abagail E. [1 ]
Watson, Kelly H. [2 ]
Baumann, Mary G. [1 ]
Pfalzer, Anna C. [2 ]
Diehl, Spencer [2 ]
Duncan, Kathleen [1 ]
McDonell, Katherine E. [2 ]
Claassen, Daniel O. [2 ]
Compas, Bruce E. [1 ]
机构
[1] Vanderbilt Univ, Dept Psychol & Human Dev, 230 Appleton Pl,PMB 552, Nashville, TN 37203 USA
[2] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN USA
关键词
Huntington disease; coping; depression; anxiety; NEUROPSYCHIATRIC SYMPTOMS; ILLNESS PERCEPTIONS; ANXIETY; CHILDREN;
D O I
10.3233/JHD-240027
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Huntington's disease (HD) presents patients and individuals at risk for HD with significant levels of stress. However, relatively little research has examined how individuals cope with stress related to the disease or the association of specific coping strategies with psychological symptoms. Objective: This study examined the ways in which HD patients and at-risk individuals cope with HD-related stress using a control-based model of coping and the association of coping strategies with symptoms of depression and anxiety. Methods: HD patients (n = 49) and at-risk individuals (n =76) completed the Responses to Stress Questionnaire - Huntington's Disease Version to assess coping strategies in response to HD-related stress, as well as standardized measures of depression and anxiety symptoms. Patient health records were accessed to obtain information related to disease characteristics. Results: Patients and at-risk individuals reported using comparable levels of primary control coping, secondary control coping, and disengagement coping strategies. In linear regression analyses, only secondary control coping was significantly associated with lower depression (9 = -0.62, p <0.001) and anxiety (9 = -0.59, p <0.001) symptoms in patients and at-risk individuals (9 = -0.55, p <0.001 and 9 = -0.50, p <0.001, respectively). Conclusions: Secondary control coping may be beneficial for both HD patients and at-risk individuals. Future research using the control-based model of coping in longitudinal studies with the HD population is needed, and future interventions could test the effects of cognitive reframing and acceptance as coping strategies for families affected by HD.
引用
收藏
页码:339 / 347
页数:9
相关论文
共 50 条
  • [31] Experience of Individuals With Huntington's Disease and Chorea
    Thorley, Eileen Mack
    Iyer, Ravi
    Carlozzi, Noelle
    Wicks, Paul
    Curran, Chris
    Gandhi, Sanjay
    Abler, Victor
    Anderson, Karen
    NEUROTHERAPEUTICS, 2018, 15 (01) : 259 - 259
  • [32] Early visual alterations in individuals at-risk of Alzheimer's disease: a multidisciplinary approach
    Lopez-Cuenca, Ines
    Nebreda, Alberto
    Garcia-Colomo, Alejandra
    Salobrar-Garcia, Elena
    de Frutos-Lucas, Jaisalmer
    Bruna, Ricardo
    Ramirez, Ana I.
    Ramirez-Torano, Federico
    Salazar, Juan J.
    Barabash, Ana
    Gil, Pedro
    Maestu, Fernando
    Ramirez, Jose M.
    de Hoz, Rosa
    ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)
  • [33] Alzheimer's disease: The effects of simvastatin on cerebral perfusion in at-risk individuals.
    Vogelman, L. C.
    Xu, G.
    Huang, Y.
    Fain, S.
    Johnson, S.
    Rowley, H.
    Gleason, C.
    Blazel, H.
    Herman, B.
    Asthana, S.
    Sager, M.
    Carlsson, C.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2010, 58 : 144 - 145
  • [34] Perceptions about Research Participation among Individuals at Risk and Individuals with Premanifest Huntington's Disease: A Survey Conducted by the European Huntington Association
    Julio, Filipa
    Blanco, Ruth
    Casanova, Jose Perez
    D'Alessio, Barbara
    De Schepper, Beatrice
    De Sousa, Dina
    De Sousa, Paul
    Ferreira, Cristina
    Gommans, Hans
    Haselberg, Rob
    Hermant, Emilie
    Lis, Danuta
    Maffi, Sabrina
    Olsen, Svein Olaf
    Papantoniou, Marios
    Squitieri, Ferdinando
    Tretyakova, Marina
    Umakhanova, Zaynab
    Vaclavik, Vladimir
    Winkelmann, Michaela
    Arnesen, Astri
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (08):
  • [35] Early visual alterations in individuals at-risk of Alzheimer’s disease: a multidisciplinary approach
    Inés López-Cuenca
    Alberto Nebreda
    Alejandra García-Colomo
    Elena Salobrar-García
    Jaisalmer de Frutos-Lucas
    Ricardo Bruña
    Ana I. Ramírez
    Federico Ramirez-Toraño
    Juan J. Salazar
    Ana Barabash
    Pedro Gil
    Fernando Maestú
    José M. Ramírez
    Rosa de Hoz
    Alzheimer's Research & Therapy, 15
  • [36] ORAL MOTOR DYSFUNCTION IN INDIVIDUALS AT RISK OF HUNTINGTON DISEASE
    COLEMAN, R
    ANDERSON, D
    LOVRIEN, E
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1990, 37 (01): : 36 - 39
  • [37] DYNAMIC MEMBRANE STUDIES IN INDIVIDUALS AT RISK FOR HUNTINGTON DISEASE
    PETTEGREW, JW
    MINSHEW, NJ
    STEWART, RM
    NEUROLOGY, 1981, 31 (04) : 151 - 151
  • [38] Factors related to genetic testing in adults at risk for Huntington disease: the prospective Huntington at-risk observational study (PHAROS)
    Quaid, K. A.
    Eberly, S. W.
    Kayson-Rubin, E.
    Oakes, D.
    Shoulson, I.
    CLINICAL GENETICS, 2017, 91 (06) : 824 - 831
  • [39] Chemical anatomy of striatal interneurons in normal individuals and in patients with Huntington's disease
    Cicchetti, F
    Prensa, L
    Wu, Y
    Parent, A
    BRAIN RESEARCH REVIEWS, 2000, 34 (1-2) : 80 - 101
  • [40] Psychosocial issues of at-risk individuals of genetic prion disease
    Tamura, Chieko
    PRION, 2014, 8 : 127 - 128